Oncological safety of omitting axillary nodal clearance in breast cancer patients Post- Neoadjuvant chemotherapy (NACT) with complete pathological response: A retrospective analysis

被引：0
|
作者：
Chougle, Q. [1 ]
Vaidhyakkaran, I. [1 ]
Saleeb, A. [1 ]
Kalyvioti, C. [1 ]
Hamed, H. [1 ]
机构：
[1] Guys & St Thomas NHS Trust, Breast Surg, London, England
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P398
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Frequency of axillary nodal complete pathological response of breast cancer patients in neoadjuvant chemotherapy setting: A cross-sectional study
    Abidi, Syeda Sakina
    Vohra, Lubna
    Kerawala, Asad Ali
    Kafeel, Annam
    Tahseen, Muhammad Umair
    Javed, Saad
    TURKISH JOURNAL OF SURGERY, 2023, 39 (02) : 136 - 144
  • [2] Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response
    Blumencranz, P.
    Habibi, M.
    Treece, T.
    Blumencranz, L.
    Yoder, E.
    Audeh, W.
    Carter, E.
    McNaughton, L.
    Roussos, J.
    Shivers, S.
    Acs, G.
    Cox, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [3] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
    Takaoka, Megumi
    Ohsumi, Shozo
    Ikejiri, Haruka
    Shidahara, Tomohiro
    Miyoshi, Yuichiro
    Takahashi, Mina
    Takashima, Seiki
    Aogi, Kenjiro
    ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
  • [4] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    BREAST, 2014, 23 (05): : 690 - 691
  • [5] The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients
    Leinert, Elena
    Lukac, Stefan
    Schwentner, Lukas
    Coenen, Antonia
    Fink, Visnja
    Veselinovic, Kristina
    Dayan, Davut
    Janni, Wolfgang
    Friedl, Thomas W. P.
    SURGICAL ONCOLOGY-OXFORD, 2024, 52
  • [6] Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease
    Goel, Neha
    Yadegarynia, Sina
    Rodgers, Steve
    Kelly, Kristin
    Collier, Amber
    Franceschi, Dido
    Moller, Mecker
    Avisar, Eli
    Kesmodel, Susan B.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (01) : 25 - 32
  • [7] Primary Tumor Response to Neoadjuvant Chemotherapy Is Significantly Associated with Nodal Pathological Complete Response in Breast Cancer Patients with Cytologically Proven Axillary Node Metastasis.
    Hwang, H.
    Park, S.
    Lee, J. S.
    Kim, S-I
    Park, B-W
    CANCER RESEARCH, 2011, 71
  • [8] FDG-PET predictivity of pathological axillary nodal status in carcinoma breast-upfront and post-neoadjuvant chemotherapy (NACT) setting
    Sekar, K.
    Lohith, R.
    Radheshyam, N.
    Kallur, K.
    Varun, K.
    Priya, S.
    Siyus, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1253 - S1253
  • [9] Does tumour biology impact upon surgery type and complete pathological response after neoadjuvant chemotherapy in breast cancer patients with axillary nodal metastases?
    Boland, M. R.
    Lowery, A. J.
    Evoy, D.
    Rothwell, J.
    Geraghty, J.
    Quinn, C.
    Gullo, G.
    Walshe, J.
    Crown, J.
    O'Doherty, A.
    McDermott, E. W.
    Prichard, R. S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S178 - S179
  • [10] Complete pathological response following neoadjuvant chemotherapy in early breast cancer: a retrospective study
    Janjua, Tanzeel
    Ramanujam, Deivasikamani
    Mausam, Iqtedar
    Ali, Waqas
    Butt, Mohammad
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S127 - S127
12345